Case Report: A recurrent case of ALK-ALCL after autologous transplantation was successfully treated with BV + a modified CHEP chemotherapy containing mitoxantrone hydrochloride liposome with the addition of chidamide maintenance therapy.

Shang, Zhen; Zhang, Qi; Liu, Wanying; Wu, Jiaying; Zhang, Yicheng; Xiao, Yi

Shang, Zhen; Zhang, Qi; Liu, Wanying; Wu, Jiaying; Zhang, Yicheng; Xiao, Yi.

Afiliação

Shang Z; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Q; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu W; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wu J; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Y; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiao Y; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Front Oncol ; 13: 1242552, 2023.

Article em En | MEDLINE | ID: mdl-37849796